12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Clinical trial NCT02107196 · COMPLETED
Trial details
- NCT number
- NCT02107196
- Sponsor
- Menarini Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-06-01
- Enrollment
- 535
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.